Highlights effective photopatch testing techniques for patients with PACD, suggesting improved clinical practice.
Photopatch testing (PPT) represents the gold standard diagnostic evaluation for photoallergic contact dermatitis (PACD), a type IV hypersensitivity reaction to an antigen that occurs in the presence of ultraviolet A radiation. The most common photoallergens in the United States are organic sunscreen filters, whereas topical NSAIDs predominate in Europe. PACD is not rare among photosensitive patients; however, PPT is underperformed in clinical practice due to several limiting factors. Herein, we provide practical approaches to PPT based on expert opinion, including straightforward recommendations on patient selection and testing procedure.
No takes yet. Share an insight, caveat, or question.
Adler et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: